Microbix Biosystems Inc.
MBXBF
$0.22
-$0.01-4.82%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 17.67% | -19.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 17.67% | -19.74% | |||
| Cost of Revenue | 4.69% | -29.44% | |||
| Gross Profit | 31.64% | -5.84% | |||
| SG&A Expenses | -2.96% | 7.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.45% | -9.99% | |||
| Operating Income | 48.95% | -33.31% | |||
| Income Before Tax | 44.77% | -22.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.77% | -22.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.77% | -22.85% | |||
| EBIT | 48.95% | -33.31% | |||
| EBITDA | 77.14% | -35.09% | |||
| EPS Basic | 44.59% | -23.33% | |||
| Normalized Basic EPS | 43.48% | -21.05% | |||
| EPS Diluted | 43.24% | -23.33% | |||
| Normalized Diluted EPS | 43.48% | -21.05% | |||
| Average Basic Shares Outstanding | -0.79% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.83% | -0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||